PharmaShots | Incisive News in 3 Shots

Subscribe Now

(ofatumumab)

Novartis' Kesimpta (ofatumumab) Receives the EC's Approval for Adult Patients with Relapsing Multiple Sclerosis

Novartis' Kesimpta (ofatumumab) Receives the EC's Approval for Adult Patients with Relapsing Multiple Sclerosis

March 30, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us